India Joins NeoSep1 Trial to Combat Neonatal Sepsis
Health & Medicine
India has joined the NeoSep1 international clinical trial, with JIPMER, Puducherry, becoming the first Indian centre to enrol a newborn. The trial aims to identify safe and effective antibiotic combinations to treat antimicrobial-resistant neonatal sepsis, a leading cause of newborn deaths.
Test your knowledge
Try these questions from this current-affairs topic.